Xiaopei Cui
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Pulmonary Hypertension Research and Treatments 7
-
- Sirtuins and Resveratrol in Medicine 2
- Co-authors
- Zhen Chen (4 shared papers)Shu Chien (2 shared papers)I‐Chen Peng (2 shared papers)Yi-Shuan Julie Li (1 shared paper)Haiqing Gao (12 shared papers)Deyue Yu (2 shared papers)Hongyang Du (2 shared papers)Xuanrui Zeng (1 shared paper)
- Journals
- Frontiers in Immunology (5 papers)Annals of Translational Medicine (2 papers)International Immunopharmacology (2 papers)Pharmacological Research (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaopei Cui
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 63
- Geriatrics and Gerontology 69
- Toxicology 56
- Biochemistry 43
- Cancer Research 82
- Molecular Biology 269
Countries citing papers authored by Xiaopei Cui
This map shows the geographic impact of Xiaopei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopei Cui more than expected).
Fields of papers citing papers by Xiaopei Cui
This network shows the impact of papers produced by Xiaopei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopei Cui. The network helps show where Xiaopei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 246 | |
| 2 | 2015 | 215 | |
| 3 | 2013 | 156 | |
| 4 | 2008 | 74 | |
| 5 | 2013 | 69 | |
| 6 | 2012 | 62 | |
| 7 | 2020 | 48 | |
| 8 | 2021 | 48 | |
| 9 | 2012 | 44 | |
| 10 | 2010 | 35 | |
| 11 | 2013 | 34 | |
| 12 | 2016 | 29 | |
| 13 | 2012 | 27 | |
| 14 | 2020 | 20 | |
| 15 | 2022 | 20 | |
| 16 | 2021 | 17 | |
| 17 | 2019 | 16 | |
| 18 | 2021 | 16 | |
| 19 | 2021 | 15 | |
| 20 | 2018 | 14 |
About Xiaopei Cui
Xiaopei Cui is a scholar working on Pulmonary and Respiratory Medicine, Geriatrics and Gerontology, Toxicology, Cardiology and Cardiovascular Medicine and Oncology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (7 papers), Cancer Immunotherapy and Biomarkers (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Forensic Toxicology and Drug Analysis (2 papers), Cardiovascular Issues in Pregnancy (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (69 citations), Toxicology (56 citations), Biochemistry (43 citations), Cancer Research (82 citations) and Molecular Biology (269 citations). Xiaopei Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhen Chen, Shu Chien, I‐Chen Peng, Yi-Shuan Julie Li, Haiqing Gao, Deyue Yu, Hongyang Du, Xuanrui Zeng, Hao Cheng and Xiangju Liu. Their work appears in journals such as Frontiers in Immunology, Annals of Translational Medicine, International Immunopharmacology, Pharmacological Research and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.